367 related articles for article (PubMed ID: 27155333)
1. Regulation of the TGF-β pathway by deubiquitinases in cancer.
Liu S; de Boeck M; van Dam H; Ten Dijke P
Int J Biochem Cell Biol; 2016 Jul; 76():135-45. PubMed ID: 27155333
[TBL] [Abstract][Full Text] [Related]
2. TGF-β signaling pathway mediated by deubiquitinating enzymes.
Kim SY; Baek KH
Cell Mol Life Sci; 2019 Feb; 76(4):653-665. PubMed ID: 30349992
[TBL] [Abstract][Full Text] [Related]
3. LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway.
Shi H; Xie J; Wang K; Li W; Yin L; Wang G; Wu Z; Ni J; Mao W; Guo C; Peng B
Cell Signal; 2021 May; 81():109932. PubMed ID: 33516780
[TBL] [Abstract][Full Text] [Related]
4. Regulation of TGF-β family signalling by ubiquitination and deubiquitination.
Imamura T; Oshima Y; Hikita A
J Biochem; 2013 Dec; 154(6):481-9. PubMed ID: 24165200
[TBL] [Abstract][Full Text] [Related]
5. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway.
Wicks SJ; Grocott T; Haros K; Maillard M; ten Dijke P; Chantry A
Biochem Soc Trans; 2006 Nov; 34(Pt 5):761-3. PubMed ID: 17052192
[TBL] [Abstract][Full Text] [Related]
6. The regulation of TGF-β/SMAD signaling by protein deubiquitination.
Zhang J; Zhang X; Xie F; Zhang Z; van Dam H; Zhang L; Zhou F
Protein Cell; 2014 Jul; 5(7):503-17. PubMed ID: 24756567
[TBL] [Abstract][Full Text] [Related]
7. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Park CY; Kim DK; Sheen YY
Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
[TBL] [Abstract][Full Text] [Related]
8. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
[TBL] [Abstract][Full Text] [Related]
9. E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression.
Sinha A; Iyengar PV; Ten Dijke P
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418880
[TBL] [Abstract][Full Text] [Related]
10. Regulation of TGF-beta family signaling by E3 ubiquitin ligases.
Inoue Y; Imamura T
Cancer Sci; 2008 Nov; 99(11):2107-12. PubMed ID: 18808420
[TBL] [Abstract][Full Text] [Related]
11. Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway.
Polimeni M; Gulino GR; Gazzano E; Kopecka J; Marucco A; Fenoglio I; Cesano F; Campagnolo L; Magrini A; Pietroiusti A; Ghigo D; Aldieri E
Part Fibre Toxicol; 2016 Jun; 13(1):27. PubMed ID: 27251132
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
13. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
Thakur AK; Nigri J; Lac S; Leca J; Bressy C; Berthezene P; Bartholin L; Chan P; Calvo E; Iovanna JL; Vasseur S; Guillaumond F; Tomasini R
Cell Death Differ; 2016 Aug; 23(8):1358-70. PubMed ID: 26943320
[TBL] [Abstract][Full Text] [Related]
14. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
15. TGF-β Signaling in Cancer.
Syed V
J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
[TBL] [Abstract][Full Text] [Related]
16. The dynamic roles of TGF-β in cancer.
Meulmeester E; Ten Dijke P
J Pathol; 2011 Jan; 223(2):205-18. PubMed ID: 20957627
[TBL] [Abstract][Full Text] [Related]
17. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
Su J; Morgani SM; David CJ; Wang Q; Er EE; Huang YH; Basnet H; Zou Y; Shu W; Soni RK; Hendrickson RC; Hadjantonakis AK; Massagué J
Nature; 2020 Jan; 577(7791):566-571. PubMed ID: 31915377
[TBL] [Abstract][Full Text] [Related]
18. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
19. The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis.
Mallikarjuna P; Zhou Y; Landström M
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625561
[TBL] [Abstract][Full Text] [Related]
20. SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitro.
O'Kane D; Jackson MV; Kissenpfennig A; Spence S; Damkat-Thomas L; Tolland JP; Smyth AE; Denton CP; Stuart Elborn J; McAuley DF; O'Kane CM
Exp Dermatol; 2014 Jul; 23(7):497-503. PubMed ID: 24848428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
